Lataa...
Analysis of the association between prior chemotherapy regimens and outcomes of subsequent anti-PD-(L)1 monotherapy in advanced non-small cell lung cancer
BACKGROUND: Immune checkpoint inhibitor (ICI) monotherapy targeting PD-1/PD-L1 has been a prominent option for the patients with advanced non-small cell lung cancer (NSCLC), which is now commonly used in second- or later-line settings after the failure of conventional chemotherapy. Chemotherapy can...
Tallennettuna:
| Julkaisussa: | Transl Lung Cancer Res |
|---|---|
| Päätekijät: | , , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
AME Publishing Company
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6976343/ https://ncbi.nlm.nih.gov/pubmed/32010570 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tlcr.2019.11.25 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|